Jascayd

Active Ingredient(s): Nerandomilast
FDA Approved: * October 7, 2025
Pharm Company: * BOEHRINGER INGELHEIM
Category: Lungs (Pulmonary)
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Jascayd 9 mg Oral Tablet, Film Coated
NDC: 0597-2465
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.
Jascayd 18 mg Oral Tablet, Film Coated
NDC: 0597-7313
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.